|View printer-friendly version|
|Array CEO Robert E. Conway to Speak At Needham & Company Biotechnology Conference|
|BOULDER, Colo., May 22, 2002 /PRNewswire-FirstCall via COMTEX/ -- Array
BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer,
Robert E. Conway, will speak at the First Annual Needham & Company Biotechnology
Conference on June 4 in New York City.
Presentation by: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Tuesday, June 4, 2002
Time: 8:30 a.m. Eastern Time
Location: Millennium Broadway Hotel, New York City
About Array BioPharma:
Array BioPharma is a drug discovery company creating new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use our integrated set of drug discovery technologies, which we call the Array Discovery Platform, to invent small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of proprietary drug candidates. For more information on Array BioPharma, please visit our web site at www.arraybiopharma.com .
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, firstname.lastname@example.org